Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
04/18/2012 | CN101524526B LSECtin的一种新用途 A new use LSECtin |
04/18/2012 | CN101394841B 快速起作用的口服肽药品 Fast-acting oral peptide drug |
04/18/2012 | CN101367834B 用于制备醇和酚的水溶性膦酰氧基甲基衍生物的方法 A water-soluble phosphine acyloxymethyl derivatives of alcohols and phenols used in the preparation of |
04/18/2012 | CN101299044B 一种多肽在制备自身免疫性肝炎诊断试剂上的应用 A polypeptide used in the preparation of a diagnostic agent of autoimmune hepatitis |
04/18/2012 | CN101272694B 新颖的乳蛋白组分及其用于预防或治疗慢性炎症疾病的应用 Novel milk protein fractions and for the prevention or treatment of chronic inflammatory diseases, the application |
04/18/2012 | CN101173279B Scirr69基因、调节bdnf转录及在生物医学研究、生物治疗药物研发中的应用 Scirr69 genes regulating bdnf transcription and in biomedical research, drug discovery and development in the application of biological treatment |
04/18/2012 | CN101095944B 一种预防和治疗前列腺炎穴位缓释贴片及其制品、制备方法和用途 A method of preventing and treating prostatitis acupuncture slow release patch and its products, preparation and use |
04/17/2012 | US8158767 Polypeptides and methods for making the same |
04/17/2012 | US8158756 Recombinant gelatins |
04/17/2012 | US8158753 Anticalins |
04/17/2012 | US8158752 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases |
04/17/2012 | US8158751 Peptides for detection of antibody to Ehrlichia ewingii |
04/17/2012 | US8158750 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
04/17/2012 | US8158749 Method for ameliorating pain by modification of NMDA receptors through inhibition of Src |
04/17/2012 | US8158669 Method for treating neovascularization |
04/17/2012 | US8158606 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
04/17/2012 | US8158603 Fragments of secreted frizzled related protein |
04/17/2012 | US8158602 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
04/17/2012 | US8158597 Modulation of diacylglycerol acyltransferase 1 expression |
04/17/2012 | US8158590 Triazole-containing releasable linkers, conjugates thereof, and methods of preparation |
04/17/2012 | US8158589 Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) |
04/17/2012 | US8158588 Loop-variant PDZ domains as biotherapeutics, diagnostics and research reagents |
04/17/2012 | US8158587 Compound having histone deacetylase-inhibiting activity, and pharmaceutical composition comprising the compound as an active ingredient |
04/17/2012 | US8158586 Inhibitors of protein kinases and uses thereof |
04/17/2012 | US8158585 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders |
04/17/2012 | US8158584 Pharmaceutical preparations comprising an ALK1-Fc fusion protein |
04/17/2012 | US8158583 Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia |
04/17/2012 | US8158582 Methods for treatment of insulin-like growth factor-1 deficiency |
04/17/2012 | US8158581 IGF-1 fusion polypeptides and therapeutic uses thereof |
04/17/2012 | US8158580 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
04/17/2012 | US8158579 Fusion protein of an exendin to modified transferrin |
04/17/2012 | US8158578 Methods for treating neurological deficits |
04/17/2012 | US8158577 Modulation of cartilage homeostasis by active domains of cell binding extracellular matrix molecules |
04/17/2012 | US8158575 Agent for the prevention and treatment of sexually transmitted diseases-I |
04/17/2012 | US8158418 Chimeric alphavirus replicon particles |
04/17/2012 | US8158157 Multi-part substitution infusion fluids and matching anticoagulants |
04/17/2012 | US8158134 Microemulsion preconcentrate, microemulsion and use thereof |
04/17/2012 | US8158132 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence |
04/17/2012 | US8158129 Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo |
04/17/2012 | US8158110 Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
04/17/2012 | US8158107 Genes and proteins associated with angiogenesis and uses thereof |
04/17/2012 | CA2506672C Il-23 for treating cutaneous wounds |
04/17/2012 | CA2499008C Compositions and methods comprising a ligand of chemerinr |
04/17/2012 | CA2498636C Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
04/17/2012 | CA2497982C Peptides and related molecules that modulate nerve growth factor activity |
04/17/2012 | CA2493323C Dual reporter gene assay |
04/17/2012 | CA2431600C Molecules with extended half-lives, compositions and uses thereof |
04/17/2012 | CA2410526C Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
04/17/2012 | CA2408380C Recombinant human cln2 protein and methods of its production and use |
04/17/2012 | CA2408328C Immunogenic polypeptides encoded by mage minigenes and uses thereof |
04/17/2012 | CA2378871C Design of beta-sheet proteins with specific binding properties |
04/17/2012 | CA2377607C Neurotrophic factor receptor |
04/17/2012 | CA2373290C Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
04/17/2012 | CA2372181C Adjuvant combination formulations |
04/17/2012 | CA2371625C Polyamines and their use in therapy |
04/17/2012 | CA2363958C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
04/17/2012 | CA2355495C Method of modulating tumor immunity |
04/17/2012 | CA2353138C Food-induced antisecretory proteins in egg yolk |
04/17/2012 | CA2347928C Cell surface molecule-induced macrophage activation |
04/17/2012 | CA2280966C Implantable collagen-containing putty material |
04/17/2012 | CA2225378C Cytokine that induces apoptosis |
04/17/2012 | CA2202090C Papilloma virus-like particles, fusion proteins as well as processes for their production |
04/17/2012 | CA2177195C Method and composition for treating renal failure |
04/17/2012 | CA2145778C Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
04/12/2012 | WO2012048334A2 Novel fungal proteases |
04/12/2012 | WO2012048291A2 Compositions and methods for inhibition of mmp:mmp-substrate interactions |
04/12/2012 | WO2012048214A2 Use of hyaluronan for promoting angiogenesis |
04/12/2012 | WO2012048190A1 Annexin ii compositions and methods |
04/12/2012 | WO2012048125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases |
04/12/2012 | WO2012048119A2 Anti-biofilm compositions and methods for using |
04/12/2012 | WO2012048033A2 Novel compositions for inhibiting virus entry and promoting virolyisis, and methods thereof |
04/12/2012 | WO2012048022A2 Methods and compositions for therapeutic modulation of aldosterone levels in heart disease |
04/12/2012 | WO2012048002A1 Self -assembling tripeptides for stabilising biomolecules |
04/12/2012 | WO2012047989A1 Tnf inhibitor formulation for use in implantable infusion devices |
04/12/2012 | WO2012047930A2 Compositions and methods for treatment of gynecologic cancers |
04/12/2012 | WO2012047852A2 Compositions and methods for modulating immunodeficiency virus transcription |
04/12/2012 | WO2012047800A1 Methods for increasing muscle glucose uptake and decreasing muscle recovery time using amino acid blend |
04/12/2012 | WO2012047764A1 Therapeutic antiviral peptides |
04/12/2012 | WO2012047763A2 Stimulation of neuroregeneration by flavonoid glycosides |
04/12/2012 | WO2012047733A2 Treatment of acne by conditioned media |
04/12/2012 | WO2012047525A2 Folate conjugates for treating inflammation of the eye |
04/12/2012 | WO2012047175A1 Fusion polypeptides comprising tir and dimerization domain for modulation of tlr/innate immunity signaling |
04/12/2012 | WO2012046922A1 Novel use of antimicrobial peptides in regeneration of skin cells |
04/12/2012 | WO2012046873A1 Method for evaluating degree of cancerization |
04/12/2012 | WO2012046730A1 Method for activating helper t cell |
04/12/2012 | WO2012046260A1 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours |
04/12/2012 | WO2012046238A2 Erythropoietin receptor antagonists |
04/12/2012 | WO2012046006A2 Cancer targets |
04/12/2012 | WO2012045801A1 Lactoferrin based complex coacervates and their uses |
04/12/2012 | WO2012045751A2 Multivalent synthetic compounds as antibiotic treatment |
04/12/2012 | WO2012045750A2 Compositions comprising multivalent synthetic ligands of surface nucleolin and glycosaminoglycans |
04/12/2012 | WO2012045704A1 New treatments of hepatitis c virus infection |
04/12/2012 | WO2012045617A1 Peptides containing tryptophan |
04/12/2012 | WO2012045569A1 Factor ii and fibrinogen for treatment of haemostatic disorders |
04/12/2012 | WO2012045334A1 Biologically active il-10 fusion proteins |
04/12/2012 | WO2012045281A1 Diagnostic and therapeutic uses of moesin fragments |
04/12/2012 | WO2012045280A1 Salts and polymorphs of sulfamide ns3 inhibitors |
04/12/2012 | WO2012045279A1 Moesin fragments associated with immune thrombocytopenia |
04/12/2012 | WO2012045275A1 Moesin fragments associated with aplastic anemia |
04/12/2012 | WO2012045274A1 Moesin modulators and uses thereof |